Let’s dig into the relative performance of Dentsply Sirona (NASDAQ:XRAY) and its peers as we unravel the now-completed Q4 ...

DENTSPLY SIRONA XRAY is well-positioned for growth due to its new digital-implant work flow and continued focus on research and development. However, forex headwinds and demand softness in Europe ...

Investors in DENTSPLY SIRONA Inc (Symbol: XRAY) saw new options begin trading this week, for the May 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ...

In this article, we are going to take a look at where DENTSPLY SIRONA Inc. (NASDAQ:XRAY) stands against other 52-week low dividend stocks to avoid. Navigating the stock market can feel like ...

LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and ...

Cerity Partners LLC grew its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 268.5% during the 4th quarter, according to the company in its most recent disclosure with the SEC.

Morgan Stanley downgraded Dentsply Sirona (NASDAQ:XRAY) to Equal Weight from Overweight and slashed its price target to $14 from $21 per share on Tuesday, noting that the dental product maker is ...

DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Thursday, May 8 ...

Morgan Stanley lowered shares of DENTSPLY SIRONA (NASDAQ:XRAY – Free Report) from an overweight rating to an equal weight rating in a report issued on Tuesday morning, MarketBeat reports.

Let’s dig into the relative performance of Dentsply Sirona (NASDAQ:XRAY) and its peers as we unravel the now-completed Q4 dental equipment & technology earnings season. The dental equipment and ...